In the world of hemp genetics, scientific meets art and history blends with innovation. From the cherry areas of Long Island to the cutting-edge of cannabis genetics, Justin Esquivel is the CEO and scientist at Green Luster Phenos. His trip is a testament to the power of roots, both interpersonal and floral.
Esquivel offers special insights into production as a officially licensed scientist with a unique approach to mating. We examine the history, current, and future of hemp breeding through the eye of an economy pioneer in this unique interview.
Cannabis Today: How did you find into cannabis?
Justin Esquivel: I started by breeding unique plants, including beans, berries and fruits. I also transplanted blue hydrangeas from Chinese elms.
CN: How much were you working with non-cannabis flowers before transitioning to cannabis?
JE: About four or five years. I’ve often grown cannabis physically, but I entered the legitimate place in November 2012.
CN: When did you first discover your love for the knowledge of agriculture?
Suis: It was definitely with berries. They’re a superfruit and my father, who passed away in 2009 from cancer and other health problems, was a large cherry producer. He had trees in his garden in Bridge Hampton, Long Island, New York, straight off Montauk Boulevard.
I had a positive impression of him and my father in the yard. I enjoy observing a seed’s normal development and structural changes while watching it grow and develop.
CN: Has cannabis often been part of your life, or were you introduced to it afterwards?
Suis: It’s always been part of my life. I’ve been a nighttime smoking since middle school and have ADHD and OCD. It’s generally worked for me.
CN: What’s your go-to rose that you’re enjoying best today?
JE: I enjoy life hash rosin and apply a Crafty vape. Now, I’m vaping some Grand Gelato, a kind two pressure. As a family, I appreciate that I may use a form two pressure and be clear-headed and focused. My go-to strains nowadays are Diesel Dessert and Grand Gelato.
CN: Do you flip through various traits, or do you have a constant pressure that works best for you biologically?
JE: I prefer sativas, but strain-wise, it’s been all over the area. One of the first strains I tried was AK-47 or Punky Lion, a uncommon a that I cultivated at house.
CN: Do you subscribe to the growing understanding of thc, terpenes and modest cannabinoids, or do you believe the sativa/indica/hybrid categorization is here to stay?
JE: There will always be a business for landrace strains, real sativas, indicas, and variants. But, I consider myself a chemovar producer. We breed for all cbd, such as CBC, CBD, THCV and THC, taking a more therapeutic approach to each child’s needs.
CN: Do you work in the business flax seed industry or do you prefer to use psychoactive or health cannabis?
JE: We supply hemp seeds to global cultivators, but we do n’t turn them into fiber or for other industrial purposes. Our emphasis is on therapeutic, wild and marijuana breeding for consumers.
CN: What’s your take on the future of psychedelic flax, given the recent DEA notice about THCA?
JE: I think we’re heading towards total legalization. We’ve seen gap after gap with a variety of cannabinoids, and I think they’ll eventually make it legal in large amounts with certain licenses for different varieties of cultivation.
CN: How popular is it to be a officially licensed scientist?
J: It’s a relatively small party. The majority of those with federal licenses work with flax to produce it rather than for breeding. Not many of us who are licensed to breed flax and have multi-state hemp production microbusiness certificates are also licensed, despite the fact that I’m not the only one. Most officially licensed operators are focused on immediate production—producing plant, concentrates, or CBD cannabis. In the industry, we are the first to combine breeding and multi-state production permissions.
CN: Please explain what a kind two cannabis stress is.
JE: Usually, hemp strains are broken down into three categories:
- Model one: High THC, lower CBD varieties
- Model three: USDA-compliant varieties with about non-detectable Cannabis and great CBD
- Model two: High THC and large CBD
I have been a big fan of type two genotypes. Around 2018, when CBD prices started to drop, they gained prominence with flax producers. Grand Gelato, our initial type two strain, was introduced to a large number of hemp farmers.
Initially, in 2018-2019, the concept was n’t widely discussed or accepted. However, type two crops were very profitable because farmers in their claims obtained COAs that were cooperative. Hemp farmers were able to get new products while those who specialized in traditional biomass struggled monetarily. This demonstrated how kind two isolates were assisting farmers in navigating the uncertainty in the sector.
CN: What are the advantages of kind two hemp for consumers?
JE: The main selling point is that CBD helps to counteract THC’s psychoactive effects. This means that form two strains of CBD may help counteract side effects like dry eye, dry lips, munchies, or stress when smoking. You get a full range advantage of all cbd.
From a grower’s view, these strains are more resilient to garden stresses like vermin and germs. Additionally, they frequently have a stronger saccharide account.
Economically, form two strains offer special options. For example, our strain Diesel Dessert tests at about 16 % THC and 16 % CBD. Farmers may use filtration and winterization to distinguish the THC and CBD from this during the harvest. They can therefore sell these as two distinct Merchandise, giving them essentially two income streams from a single grain. This makes kind two strains very adaptable and profitable.
CN: How is Green Luster Phenos ‘ view to breeding special?
JE: At Green Luster Phenos, we practice “plasticity breeding”. While some might suggest it’s really pest-resistant breeding, our view is more complex. We’re interior, sealed, cubic-feet producers, focusing on stabilizing flexibility across all alleles within each engineered stress. We have breeding centers set up for particular geographical areas, such as Texas and different East Coast areas. This enables us to adapt our breeding to particular economic circumstances.
Our flexibility rearing involves techniques like releasing targeted fungus fly larvae in 35-gallon totes. Over about 36 weeks of breeding, we select alleles that show great resistance to specific mosquito pressures. In order to breed for PM weight, we might even separate powdery mildew seeds in Petri dishes.
With the help of this comprehensive view, we can create custom genetics that are appropriate for all countries where cannabis producers are grown, taking into account both economic and pest factors. It employs a comprehensive approach that transcends simple pest resistance to produce truly adaptable and resilient strains.
CN: Where do your biology come from?
J: Our genetics come from all over the globe. We combine well-known US strains with wild genetics from various nations. For instance, our Cream 47 pressure combines a cut from a family homestead in Durango, Mexico, with Oreos, a prominent Michigan stress. Additionally, we work to combine older varieties with new people to maintain and enhance older varieties.
CN: What are the importance and relevance of landrace genotypes in the sector?
JE: Landrace strains are favored by consumers because of their common crew effects and historical connection to cannabis. As a producer and scientist, I’m serious in their genetic purity. Many of the landrace strains that are advertised are diluted, so I always find true form at the cause. This level of purity is essential for breeding programs to accurately highlight particular qualities.
CN: Are F1 variants the future of production?
JE: I would n’t say they’re the future. Some growers favor varieties for their uniqueness without real domesticated lines. F1 versions are great for commercial-scale outside operations. We have numerous F1 types ourselves. Triploids are being bred, and various hemp varieties are being tested. There will always be demand for more variety, but I believe cell society will eventually take the place of variety.
CN: Will cell society be the main transmission method for large-scale agriculture?
JE: I believe it will be required due to problems like mosaic disease and climb latent virus. In the USA, we tested seeds and replicas, and 82 % of the results were positive for climb latent virus. For business operators to guarantee sustainability and regularity, they’ll have to implement tissue culture. It’s a no-brainer.
CN: Is cell society more capital-intensive than grain or clone strategies?
JE: No, it’s truly cost-effective. We have saved hundreds of thousands of dollars in labor thanks to cell culture. We maintain sterile, in vitro tissues that do n’t require daily care. Before needing repair, they continue to grow in freezer for up to a year. This enables business owners to turn family rooms into profitable rose production areas. It’s a game-changer and no expensive to implement.
CN: How prevalent is muscle culture today among business cultivators?
JE: No some. It’s a novel crop, but it’s been used for centuries in conventional farming. It is growing in popularity as a result of pathogens like mosaic virus and climb hidden viroid. However, I do n’t think tissue culture will be the complete standard. We’re even focusing on breeding for homozygosity stability using sophisticated tools like marker-assisted selection, Line and HPLC.
CN: Do you respond to business owners or household producers?
JE: We’re split equally between the two. Our biology are grown in 43 states and 19 countries, immediately to get 20 with the Czech Republic. Half of our customers, even abroad, are home gardeners and third are industrial cultivators.
CN: How do you stabilize prices for seeds, considering their probable offer?
Suis: Our costs has not changed. We do n’t do promotions or sales, except for veteran discounts. The work that goes into creating each stress is reflected in the firm pricing. We’re currently working on strains to be released in 2026, which gives you an idea of our arranging schedule.
CN: Wow, you’re two, three times out on anything?
JE: That’s how we’ve niched ourselves. We do n’t drop strains every few months or even yearly. We’re creating custom biology to fit the needs of farmers and the current market. There’s a lot of work, looking and tests involved. Customers are n’t just paying for seeds, they’re paying for genetics, consistency and trust in our brand.
CN: Is your company focus mainly on the US industry, or are international businesses gaining attention?
JE: It’s world. I love traveling, meeting unique producers, seeing their designs and understanding their problems. I apply that knowledge over the course of 24-36 times to create unique options. It’s about making the effort to add price. As a young entrepreneur with a home, I’m focused on both the manifest and the tradition we’re leaving behind for the long run.
CN: How do you include education and public speaking into your business plan?
J: It’s base to who I am as a man and entrepreneur. I enjoy speaking to organizations of all size and educating them. Folks telling me how much they’ve learned gives me the pleasure. I prefer hands-on, in-person marketing over social media contacts. It’s about love and raising knowledge in the industry.
What do you think the hemp economy and Green Luster Phenos will look forward to in the next ten years, CN?
JE: For Green Luster Phenos, we’re committed to staying true to our origins. I think it’s better to master a topic than to diversify too much. Our emphasis will stay on creating tailored, elite, wild biology for growers abroad. We’ll continue to innovate, with a special emphasis on full-spectrum hemp compounds.
For instance, we just developed a strain with no cbd but 7.7 % full compounds, which took almost 40 weeks to perfect. The objective was to push the boundaries of what can be done in cannabis breeding by extracting significant amounts of terpenes under a cannabis license.
Looking ahead, I see branding becoming increasingly vital in the cannabis business. Some companies focus only on the item, the bud, the dispensary or their following SKU. Nevertheless, I believe brand identity and faith will be the key differentiators.
The cannabis market will likely change also to the beer and wine industries, where consumers will have strong brand preferences. Businesses that can establish and maintain a reliable company with consistently excellent products will stand out in today’s market where value is at a superior and quality may be contradictory.
For the business as a whole, I anticipate a move towards model precision. Customers of cannabis will gravitate toward brands they can trust and love in the same way that people have their favourite wines or beers. This tendency towards brand loyalty may form the company’s coming, driving businesses to concentrate not just on their products, but on building lasting relationships with their customers through solid, dependable brand.
